Re:Another drug approved despite review board
by jjoonathan on Monday June 24, 2024 @11:34AM
(#40777310)
They were able to assess the efficacy by looking for illness, not death. It takes some verrrry "special" framing to twist this into anything but an enormous success:
> BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6).
Yet the deaths clearly mattered when multiplied up to population scale, because COVID was able to fill up the hospitals.
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577